National Health Investors Stock Forecast, Price & News

National Health Investors' stock was trading at $70.86 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, NHI shares have decreased by 8.6% and is now trading at $64.76.
View which stocks have been most impacted by COVID-19.

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for National Health Investors in the last year. There are currently 2 sell ratings and 6 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" National Health Investors stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NHI, but not buy additional shares or sell existing shares.
View analyst ratings for National Health Investors or view MarketBeat's top 5 stock picks.

Wall Street analysts have given National Health Investors a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but National Health Investors wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

National Health Investors is scheduled to release its next quarterly earnings announcement on Monday, February 22nd 2021.
View our earnings forecast for National Health Investors.

National Health Investors will be holding an earnings conference call on Monday, February 22nd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

National Health Investors, Inc. (NYSE:NHI) issued its earnings results on Monday, November, 9th. The real estate investment trust reported $0.95 earnings per share for the quarter, missing analysts' consensus estimates of $1.43 by $0.48. The real estate investment trust earned $84.30 million during the quarter, compared to analysts' expectations of $82.87 million. National Health Investors had a trailing twelve-month return on equity of 12.64% and a net margin of 56.94%. The company's revenue for the quarter was up 3.2% on a year-over-year basis. During the same period in the previous year, the firm earned $1.42 EPS.
View National Health Investors' earnings history.

National Health Investors announced a quarterly dividend on Tuesday, December 15th. Investors of record on Thursday, December 31st will be given a dividend of $1.102 per share on Friday, January 29th. This represents a $4.41 dividend on an annualized basis and a yield of 6.81%. The ex-dividend date of this dividend is Wednesday, December 30th.
View National Health Investors' dividend history.

National Health Investors pays an annual dividend of $4.41 per share and currently has a dividend yield of 6.65%. NHI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. National Health Investors has been increasing its dividend for 11 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of National Health Investors is 80.18%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, National Health Investors will have a dividend payout ratio of 78.05% in the coming year. This indicates that National Health Investors may not be able to sustain their current dividend.
View National Health Investors' dividend history.

8 brokerages have issued 12 month price objectives for National Health Investors' stock. Their forecasts range from $40.00 to $94.00. On average, they expect National Health Investors' stock price to reach $64.29 in the next twelve months. This suggests that the stock has a possible downside of 0.7%.
View analysts' price targets for National Health Investors or view Wall Street analyst' top-rated stocks.

Some companies that are related to National Health Investors include American Tower (AMT), Public Storage (PSA), Welltower (WELL), Weyerhaeuser (WY), Ventas (VTR), Extra Space Storage (EXR), Medical Properties Trust (MPW), Omega Healthcare Investors (OHI), CubeSmart (CUBE), Life Storage (LSI), Rayonier (RYN), Healthcare Realty Trust (HR), Ryman Hospitality Properties (RHP), Sabra Health Care REIT (SBRA) and PotlatchDeltic (PCH).
View all of NHI's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other National Health Investors investors own include AT&T (T), AbbVie (ABBV), Verizon Communications (VZ), Cisco Systems (CSCO), Annaly Capital Management (NLY), JPMorgan Chase & Co. (JPM), Simon Property Group (SPG), Energy Transfer (ET), QUALCOMM (QCOM) and Broadcom (AVGO).

National Health Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "NHI."

National Health Investors' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Strs Ohio (0.15%), Pinnacle Financial Partners Inc. (0.10%), Nisa Investment Advisors LLC (0.07%), Janney Montgomery Scott LLC (0.06%), CWM LLC (0.04%) and Wiley BROS. Aintree Capital LLC (0.03%). Company insiders that own National Health Investors stock include D Eric Mendelsohn, James R Jobe, Kevin Carlton Pascoe, Robert A Mccabe, Jr, Robert G Adams, Robert T Webb and W Andrew Adams.
View institutional ownership trends for National Health Investors.

NHI stock was sold by a variety of institutional investors in the last quarter, including Csenge Advisory Group, Strs Ohio, and Janney Montgomery Scott LLC. Company insiders that have sold National Health Investors company stock in the last year include D Eric Mendelsohn, and Kevin Carlton Pascoe.
View insider buying and selling activity for National Health Investors or view top insider-selling stocks.

NHI stock was acquired by a variety of institutional investors in the last quarter, including Sound Income Strategies LLC, Pinnacle Financial Partners Inc., Redpoint Investment Management Pty Ltd, CWM LLC, New York State Teachers Retirement System, Brookstone Capital Management, Nisa Investment Advisors LLC, and Wiley BROS. Aintree Capital LLC. Company insiders that have bought National Health Investors stock in the last two years include Robert G Adams, Robert T Webb, and W Andrew Adams.
View insider buying and selling activity for National Health Investors or or view top insider-buying stocks.

Shares of NHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NHI stock can currently be purchased for approximately $64.76.

National Health Investors has a market capitalization of $2.90 billion and generates $318.08 million in revenue each year. The real estate investment trust earns $160.46 million in net income (profit) each year or $5.50 on an earnings per share basis. National Health Investors employs 17 workers across the globe.

The official website for National Health Investors is www.nhireit.com.

National Health Investors' mailing address is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. The real estate investment trust can be reached via phone at 615-890-9100 or via email at [email protected]